Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Hong Kong · Delayed Price · Currency is HKD

0.7000

+0.0500 (7.69%)

Jul 31, 2026, 3:56 PM HKT

-16.67% (1Y)

Market Cap	604.52M -16.7%
Revenue (ttm)	1.93B -21.6%
Net Income	19.24M -81.8%
EPS	0.02 -81.8%
Shares Out	863.60M
PE Ratio	31.45
Forward PE	n/a
Dividend	0.05 (7.14%)
Ex-Dividend Date	May 23, 2025

Volume	301,000
Open	0.6400
Previous Close	0.6500
Day's Range	0.6400 - 0.7200
52-Week Range	0.5000 - 0.9800
Beta	0.41
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing and property management... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1993

Employees 2,284

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 3737

Full Company Profile

Financial Performance

In 2025, HKG:3737's revenue was 1.74 billion, a decrease of -21.55% compared to the previous year's 2.21 billion. Earnings were 17.29 million, a decrease of -81.84%.

Financial numbers in CNY Financial Statements